×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Eric Benevich


Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 13, 2026Option/RSU Exercise-4,044-56,664Feb 17, 2026, 05:46 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 12, 2026Tax Payment (Shares)$123.101,082133,19453,678Feb 17, 2026, 05:46 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 12, 2026Option/RSU Exercise-2,005-54,760Feb 17, 2026, 05:46 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 13, 2026Tax Payment (Shares)$124.1211,1451,383,31763,190Feb 17, 2026, 05:46 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 31, 2026Tax Payment (Shares)$136.061,292175,79052,755Feb 03, 2026, 06:21 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 31, 2026Option/RSU Exercise-2,294-54,047Feb 03, 2026, 06:21 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 28, 2025Option/RSU Exercise$35.9912,830461,75257,723Jan 16, 2026, 05:17 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 28, 2025Option/RSU Exercise$35.995,970214,86050,863Dec 02, 2025, 05:21 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 28, 2025Sale$151.745,970905,88144,893Dec 02, 2025, 05:21 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 13, 2025Option/RSU Exercise-4,044-45,745Feb 14, 2025, 06:03 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 13, 2025Sale$116.732,154251,42844,689Feb 14, 2025, 06:03 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 10, 2025Sale$118.31980115,94042,799Feb 12, 2025, 06:44 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 08, 2025Option/RSU Exercise-1,860-43,779Feb 12, 2025, 06:44 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 31, 2025Option/RSU Exercise-2,294-43,126Feb 04, 2025, 05:35 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 31, 2025Sale$152.941,207184,59941,919Feb 04, 2025, 05:35 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerApr 15, 2024Option/RSU Exercise$81.2119,8181,609,43153,365Apr 17, 2024, 05:19 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerApr 15, 2024Sale$133.3619,8182,643,02040,778Apr 17, 2024, 05:19 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerMar 14, 2024Option/RSU Exercise$80.9075,0006,067,628110,299Mar 15, 2024, 05:33 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerMar 14, 2024Sale$139.3875,00010,453,41840,778Mar 15, 2024, 05:33 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 28, 2024Option/RSU Exercise$53.6775,0004,025,04393,759Feb 29, 2024, 06:55 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 28, 2024Sale$134.6975,00010,101,60740,616Feb 29, 2024, 06:55 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 13, 2024Sale$133.011,098146,05040,616Feb 15, 2024, 05:29 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 06, 2024Sale$142.121,280181,91038,751Feb 08, 2024, 07:15 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 08, 2024Sale$134.19980131,50939,631Feb 08, 2024, 07:15 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 31, 2024Sale$140.781,207169,92737,601Feb 02, 2024, 07:05 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerAug 21, 2023Sale$107.401,600171,83636,436Aug 23, 2023, 07:59 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 08, 2023Sale$104.12980102,03634,381Feb 08, 2023, 07:18 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 06, 2023Sale$105.631,280135,20117,879Feb 08, 2023, 07:18 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 07, 2023Sale$102.4117,3901,780,86833,501Feb 08, 2023, 07:18 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 31, 2023Sale$109.951,207132,71016,729Feb 02, 2023, 05:00 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 06, 2023Option/RSU Exercise$43.2440017,29616,043Jan 10, 2023, 05:13 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 06, 2023Sale$125.0040050,00015,643Jan 10, 2023, 05:13 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 30, 2022Option/RSU Exercise$41.4750,0002,073,27537,805Dec 01, 2022, 06:43 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 30, 2022Sale$125.9050,0006,295,10015,643Dec 01, 2022, 06:43 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 08, 2022Option/RSU Exercise$41.7824,5931,027,49640,236Nov 10, 2022, 05:50 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 08, 2022Sale$125.3324,5933,082,31415,643Nov 10, 2022, 05:50 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 10, 2022Option/RSU Exercise$41.781004,17815,743Nov 10, 2022, 05:50 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 10, 2022Sale$125.3610012,53615,643Nov 10, 2022, 05:50 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 02, 2022Option/RSU Exercise$41.7840016,71216,043Nov 04, 2022, 04:56 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 02, 2022Sale$125.0040050,00015,643Nov 04, 2022, 04:56 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 03, 2022Option/RSU Exercise$41.788,968374,68324,611Nov 04, 2022, 04:56 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 03, 2022Sale$125.028,9681,121,17915,643Nov 04, 2022, 04:56 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerOct 17, 2022Sale$110.824,960549,68215,643Oct 19, 2022, 05:55 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 07, 2022Sale$80.784,119332,74819,459Feb 09, 2022, 06:53 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 08, 2022Sale$79.6798078,07320,338Feb 09, 2022, 06:53 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerAug 16, 2021Sale$89.625,628504,39515,608Aug 18, 2021, 06:18 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 05, 2021Sale$114.0380992,24716,434Feb 09, 2021, 09:26 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 08, 2021Sale$116.834,270498,84321,099Feb 09, 2021, 09:26 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 25, 2021Option/RSU Exercise$41.783,477145,26920,882Jan 27, 2021, 08:58 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 25, 2021Sale$120.035,077609,37017,405Jan 27, 2021, 08:58 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 26, 2021Option/RSU Exercise$41.7830012,53416,105Jan 27, 2021, 08:58 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJan 26, 2021Sale$120.0040048,00015,805Jan 27, 2021, 08:58 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 12, 2020Sale$90.712,257204,72317,405Nov 16, 2020, 06:27 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 02, 2020Sale$96.5320,5951,987,97215,374Nov 04, 2020, 06:09 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerNov 02, 2020Option/RSU Exercise$35.9920,595741,21435,969Nov 04, 2020, 06:09 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerAug 05, 2020Sale$118.852,257268,25315,374Aug 07, 2020, 06:35 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerApr 24, 2020Sale$99.451,934192,33813,344Apr 28, 2020, 08:33 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerApr 15, 2020Sale$94.658,632817,01811,603Apr 17, 2020, 09:48 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 07, 2020Sale$103.322,030209,74820,087Feb 11, 2020, 07:08 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 05, 2020Sale$103.031,954201,31117,007Feb 07, 2020, 06:35 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 06, 2020Sale$101.481,395141,56018,262Feb 07, 2020, 06:35 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJul 15, 2019Sale$87.445,835510,20114,910Jul 17, 2019, 07:06 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 06, 2019Sale$83.5792076,88320,745Feb 08, 2019, 05:06 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 05, 2019Sale$88.011,357119,42719,015Feb 06, 2019, 05:59 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerJun 01, 2018Sale$97.3412,3501,202,16416,690Jun 05, 2018, 06:53 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 05, 2018Sale$83.1482068,1742,577Feb 07, 2018, 06:00 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 06, 2018Tax Payment (Shares)$82.4891775,6344,310Feb 07, 2018, 06:00 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 06, 2017Sale$43.1182135,3930Feb 08, 2017, 07:40 PM
NBIXNEUROCRINE BIOSCIENCES INCEric BenevichChief Commercial OfficerFeb 07, 2017Sale$44.651325,8941,222Feb 08, 2017, 07:40 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe